Abstract
Background
Obstructive sleep apnea (OSA) occurs in 2% of middle-aged women and 4% of middle-aged men in the general population and the prevalence is much higher in specific patient groups. Intermittent hypoxia (IH, oxygen desaturation and re-oxygenation) cycle, a major pathophysiologic character of OSA, and the physiological responses this evokes are thought to be responsible for its association with increased cardiovascular morbidity and mortality. Endothelial dysfunction, resulting from IH and as a key early event in atherosclerosis, was demonstrated repeatedly in patients with OSA and in animal models of IH, providing an important mechanistic link between the acute cyclical IH during sleep and the increased prevalence of chronic vascular diseases.
Conclusions
From this work, we conclude that IH from OSA may result in endothelial dysfunction, as a potential promoter of atherosclerosis, through nitric oxide unavailability, oxidative stress and inflammation, cell apoptosis, the crosstalk between endothelial cells and circulating inflammatory cells, microparticles, and damage repairing process. Though effective continuous positive airway pressure (CPAP) may specifically improve endothelial function, more controlled larger interventional trials that will include multiple centers and randomized allocation of CPAP therapy are needed to see if such changes are reversible before cause and effect can be implied finally, while further studies on cellular and animal level are also needed to elucidate molecular biologic/pathologic pathways.
Similar content being viewed by others
References
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235
Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160:1101–1106
Hanly PJ, Pierratos A (2001) Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 344:102–107
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353:2034–2041
Young T, Evans L, Finn L, Palta M (1997) Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 20:705–706
Feng J, Chen BY, Cui LY, Wang BL, Liu CX, Chen PF, Guo MN, Dong LX, Li S (2009) Inflammation status of rabbit carotid artery model endothelium during intermittent hypoxia exposure and its relationship with leptin. Sleep Breath 13:277–283
Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939
Khayat R, Patt B, Hayes D Jr (2009) Obstructive sleep apnea: the new cardiovascular disease. Part I: obstructive sleep apnea and the pathogenesis of vascular disease. Heart Fail Rev 14:143–153
Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, Colombo PC, Basner RC, Factor P, LeJemtel TH (2008) Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117:2270–2278
Kuzkaya N, Weissmann N, Harrison DG, Dikalov S (2003) Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278:22546–22554
Atkeson A, Jelic S (2008) Mechanisms of endothelial dysfunction in obstructive sleep apnea. Vasc Health Risk Manag 4:1327–1335
Martin K, Stanchina M, Kouttab N, Harrington EO, Rounds S (2008) Circulating endothelial cells and endothelial progenitor cells in obstructive sleep apnea. Lung 186:145–150
Carreras A, Rojas M, Tsapikouni T, Montserrat JM, Navajas D, Farré R (2010) Obstructive apneas induce early activation of mesenchymal stem cells and enhancement of endothelial wound healing. Respir Res 11:91
Feng J, Chen BY, Cui LY (2008) Carotid body-mediated changes of sympathetic nerve and their relationships with hypertension. Chin Med J (Engl) 121:1732–1735
Feng J, Chiang AA-P, Wu Q, Chen BY, Cui LY, Liang D-C, Zhang Z-L, Yao W (2010) Sleep-related hypoxemia aggravates systematic inflammation in emphysematous rats. Chin Med J (Engl) 123:2392–2399
Feng J, Wang QS, Chiang A, Chen BY (2010) The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats. PLoS ONE 5:e13201
Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667
Li C, Jackson RM (2002) Reactive species mechanisms of cellular hypoxia–reoxygenation injury. Am J Physiol Cell Physiol 282:C227–C241
Feng J, Chen BY, Guo MN, Cao J, Zhao HY, Liang DC, Zuo AJ (2007) Interleukin-6 and tumor necrosis factor-alpha levels of endothelial cells in different hypoxia modes: in vitro experiment. Zhonghua Yi Xue Za Zhi 87:774–777
Feng J, Chen BY, Guo MN, Cao J, Zhao HY, Liang DC, Zuo AJ (2007) Changes of nuclear factor-kappaB and intercellular adhesion molecule-1 in endothelial cells exposed to various intermittent hypoxia. Zhonghua Jie He He Hu Xi Za Zhi 30:202–206
Peng YJ, Prabhakar NR (2003) Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia. J Appl Physiol 94:2342–2349
Prabhakar NR, Fields RD, Baker T, Fletcher EC (2001) Intermittent hypoxia: cell to system. Am J Physiol Lung Cell Mol Physiol 281:L524–L528
Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O'Connor GT, Boland LL, Schwartz JE, Samet JM (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19–25
Malhotra A, White DP (2002) Obstructive sleep apnoea. Lancet 360:237–245
Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G (2005) Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172:613–618
Savransky V, Nanayakkara A, Li J, Bevans S, Smith PL, Rodriguez A, Polotsky VY (2007) Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175:1290–1297
Budhiraja R, Parthasarathy S, Quan SF (2007) Endothelial dysfunction in obstructive sleep apnea. J Clin Sleep Med 3:409–415
Budhiraja R, Tuder RM, Hassoun PM (2004) Endothelial dysfunction in pulmonary hypertension. Circulation 109:159–165
Aird WC (2007) Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100:174–190
Ip MS, Tse HF, Lam B, Tsang KW, Lam WK (2004) Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169:348–353
Yim-Yeh S, Rahangdale S, Nguyen AT, Jordan AS, Novack V, Veves A, Malhotra A (2010) Obstructive sleep apnea and aging effects on macrovascular and microcirculatory function. Sleep 33:1177–1183
Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, Ouchi Y (1999) Increased levels of circulating ICAM-1, VCAM-1, and l-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87:10–14
Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M, Ohi M (2000) Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109:562–567
Budhiraja R, Quan SF (2005) Sleep-disordered breathing and cardiovascular health. Curr Opin Pulm Med 11:501–506
Lattimore JL, Wilcox I, Skilton M, Langenfeld M, Celermajer DS (2006) Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 61:491–495
Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109:III-27–III-32
Yang R, Sikka G, Larson J et al (2011) Restoring leptin signaling reduces hyperlipidemia and improves vascular stiffness induced by chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol 300:H1467–H1476
Panaree B, Chantana M, Wasana S et al (2010) Effects of obstructive sleep apnea on serum brain-derived neurotrophic factor protein, cortisol, and lipid levels. Sleep Breath (in press)
Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053
Nguyen PK, Katikireddy CK, McConnell MV, Kushida C, Yang PC (2010) Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea. J Cardiovasc Magn Reson 12:50
Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7:35–51
Tanaka T, Nakamura H, Yodoi J, Bloom ET (2005) Redox regulation of the signaling pathways leading to eNOS phosphorylation. Free Radic Biol Med 38:1231–1242
Antoniades C, Shirodaria C, Warrick N, Cai S, de Bono J, Lee J, Leeson P, Neubauer S, Ratnatunga C, Pillai R, Refsum H, Channon KM (2006) 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114:1193–1201
Channon KM (2004) Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med 14:323–327
Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Lüscher T, Rabelink T (1997) Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99:41–46
Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK (2002) Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106:57–62
Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, Lam WK (2000) Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162:2166–2171
Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lücke C, Mayer K, Olschewski H, Seeger W, Grimminger F (2000) Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 55:1046–1051
Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, Santa T, Imai K, Hashimoto M, Yoshizumi M, Ouchi Y (2005) Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure—possible involvement of nitric oxide and asymmetric NG,NG-dimethylarginine. Circ J 69:221–226
Tahawi Z, Orolinova N, Joshua IG, Bader M, Fletcher EC (2001) Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J Appl Physiol 90:2007–2013, discussion 2000
Lavie L, Hefetz A, Luboshitzky R, Lavie P (2003) Plasma levels of nitric oxide and l-arginine in sleep apnea patients: effects of nCPAP treatment. J Mol Neurosci 21:57–63
Clarkson AN, Liu H, Rahman R, Jackson DM, Appleton I, Kerr DS (2005) Clomethiazole: mechanisms underlying lasting neuroprotection following hypoxia–ischemia. FASEB J 19:1036–1038
Juonala M, Viikari JS, Alfthan G, Marniemi J, Kähönen M, Taittonen L, Laitinen T, Raitakari OT (2007) Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study. Circulation 116:1367–1373
Ungvari Z, Csiszar A, Bagi Z, Koller A (2002) Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: morphological and functional evidence for increased peroxynitrite formation. Am J Pathol 161:145–153
Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task Force (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265
Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA (2004) Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169:354–360
Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J (2001) Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 119:1085–1091
Grebe M, Eisele HJ, Weissmann N, Schaefer C, Tillmanns H, Seeger W, Schulz R (2006) Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 173:897–901
Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, Somers VK (2000) Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102:2607–2610
Jurado-Gámez B, Fernandez-Marin MC, Gómez-Chaparro JL et al (2010) Relationship of oxidative stress and endothelial dysfunction in sleep apnoea. Eur Respir J 37:873–879
Patt BT, Jarjoura D, Haddad DN, Sen CK, Roy S, Flavahan NA, Khayat RN (2010) Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea. Am J Respir Crit Care Med 182:1540–1545
Prabhakar NR (2002) Sleep apneas: an oxidative stress? Am J Respir Crit Care Med 165:859–860
Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566–570
Barceló A, Miralles C, Barbé F, Vila M, Pons S, Agustí AG (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16:644–647
Zweier JL (1998) Free radical generation in human endothelial cells exposed to anoxia and reoxygenation. Transplant Proc 30:4228–4232
Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555:589–606
El Solh AA, Saliba R, Bosinski T, Grant BJ, Berbary E, Miller N (2006) Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 27:997–1002
Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27:123–128
Svatikova A, Wolk R, Wang HH, Otto ME, Bybee KA, Singh RJ, Somers VK (2004) Circulating free nitrotyrosine in obstructive sleep apnea. Am J Physiol Regul Integr Comp Physiol 287:R284–R287
Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, Lerman A, Mancia G, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Schiffrin EL, Taddei S, Webb DJ, Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension (2005) Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 23:7–17
Schulz R (2005) The vascular micromilieu in obstructive sleep apnoea. Eur Respir J 25:780–782
Harrison DG, Cai H, Landmesser U, Griendling KK (2003) Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4:51–61
Büchner NJ, Quack I, Woznowski M et al (2011) Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy. Respiration (in press)
Lavie L (2005) Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach. Neurol Clin 23:1059–1075
Puig F, Rico F, Almendros I, Montserrat JM, Navajas D, Farre R (2005) Vibration enhances interleukin-8 release in a cell model of snoring-induced airway inflammation. Sleep 28:1312–1316
Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF (2006) Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343:591–596
Williams A, Scharf SM (2007) Obstructive sleep apnea, cardiovascular disease, and inflammation—is NF-kappaB the key? Sleep Breath 11:69–76
Li RC, Row BW, Gozal E, Kheirandish L, Fan Q, Brittian KR, Guo SZ, Sachleben LR Jr, Gozal D (2003) Cyclooxygenase 2 and intermittent hypoxia-induced spatial deficits in the rat. Am J Respir Crit Care Med 168:469–475
Wu G, Mannam AP, Wu J, Kirbis S, Shie JL, Chen C, Laham RJ, Sellke FW, Li J (2003) Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF. Am J Physiol Heart Circ Physiol 285:H2420–H2429
Antman EM, DeMets D, Loscalzo J (2005) Cyclooxygenase inhibition and cardiovascular risk. Circulation 112:759–770
El-Solh AA, Mador MJ, Sikka P, Dhillon RS, Amsterdam D, Grant BJ (2002) Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 121:1541–1547
Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809
Price DT, Loscalzo J (1999) Cellular adhesion molecules and atherogenesis. Am J Med 107:85–97
Larkin EK, Rosen CL, Kirchner HL, Storfer-Isser A, Emancipator JL, Johnson NL, Zambito AM, Tracy RP, Jenny NS, Redline S (2005) Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 111:1978–1984
Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134
Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor PH, Le Jemtel TH (2010) Vascular inflammation in obesity and sleep apnea. Circulation 121:1014–1021
Tricot O, Mallat Z, Heymes C, Belmin J, Lesèche G, Tedgui A (2000) Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 101:2450–2453
Dhar-Mascareño M, Cárcamo JM, Golde DW (2005) Hypoxia–reoxygenation-induced mitochondrial damage and apoptosis in human endothelial cells are inhibited by vitamin C. Free Radic Biol Med 38:1311–1322
Zhang Y, Zhang X, Park TS, Gidday JM (2005) Cerebral endothelial cell apoptosis after ischemia–reperfusion: role of PARP activation and AIF translocation. J Cereb Blood Flow Metab 25:868–877
Farber A, Kitzmiller T, Morganelli PM, Pfeiffer J, Groveman D, Wagner RJ, Cronenwett JL, Powell RJ (1999) A caspase inhibitor decreases oxidized low-density lipoprotein-induced apoptosis in bovine endothelial cells. J Surg Res 85:323–330
Alvarez RJ, Gips SJ, Moldovan N, Wilhide CC, Milliken EE, Hoang AT, Hruban RH, Silverman HS, Dang CV, Goldschmidt-Clermont PJ (1997) 17beta-Estradiol inhibits apoptosis of endothelial cells. Biochem Biophys Res Commun 237:372–381
El Solh AA, Akinnusi ME, Baddoura FH, Mankowski CR (2007) Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction. Am J Respir Crit Care Med 175:1186–1191
Santore MT, McClintock DS, Lee VY, Budinger GR, Chandel NS (2002) Anoxia-induced apoptosis occurs through a mitochondria-dependent pathway in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 282:L727–L734
Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, Kimura H (2005) Oxidative stress in obstructive sleep apnea. Chest 127:1674–1679
Tan KC, Chow WS, Lam JC, Lam B, Wong WK, Tam S, Ip MS (2006) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184:377–382
Ichikawa H, Flores S, Kvietys PR, Wolf RE, Yoshikawa T, Granger DN, Aw TY (1997) Molecular mechanisms of anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Circ Res 81:922–931
Hansson GK (2001) Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21:1876–1890
Lefer AM (1999) Role of the beta2-integrins and immunoglobulin superfamily members in myocardial ischemia–reperfusion. Ann Thorac Surg 68:1920–1923
Nácher M, Serrano-Mollar A, Farré R, Panés J, Seguí J, Montserrat JM (2007) Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir Physiol Neurobiol 155:93–96
Cadroy Y, Dupouy D, Boneu B, Plaisancié H (2000) Polymorphonuclear leukocytes modulate tissue factor production by mononuclear cells: role of reactive oxygen species. J Immunol 164:3822–3828
Chinda D, Umeda T, Shimoyama T, Kojima A, Tanabe M, Nakaji S, Sugawara K (2003) The acute response of neutrophil function to a bout of judo training. Luminescence 18:278–282
Dyugovskaya L, Polyakov A, Ginsberg D et al (2010) Molecular pathways of spontaneous and TNF-{alpha}-mediated neutrophil apoptosis under intermittent hypoxia. Am J Respir Cell Mol Biol (in press)
Dyugovskaya L, Polyakov A, Lavie P, Lavie L (2008) Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 177:544–554
Chello M, Anselmi A, Spadaccio C, Patti G, Goffredo C, Di Sciascio G, Covino E (2007) Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg 83:1374–1380
Ruchaud-Sparagano MH, Drost EM, Donnelly SC, Bird MI, Haslett C, Dransfield I (1998) Potential pro-inflammatory effects of soluble E-selectin upon neutrophil function. Eur J Immunol 28:80–89
Wahle M, Greulich T, Baerwald CG, Häntzschel H, Kaufmann A (2005) Influence of catecholamines on cytokine production and expression of adhesion molecules of human neutrophils in vitro. Immunobiology 210:43–52
Alzoghaibi MA, Bahammam AS (2005) Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep Breath 9:119–126
Htoo AK, Greenberg H, Tongia S, Chen G, Henderson T, Wilson D, Liu SF (2006) Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 10:43–50
Dyugovskaya L, Lavie P, Lavie L (2005) Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann NY Acad Sci 1051:340–350
Foster GE, Poulin MJ, Hanly PJ (2007) Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol 92:51–65
Dyugovskaya L, Lavie P, Lavie L (2003) Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 168:242–249
Dyugovskaya L, Lavie P, Hirsh M, Lavie L (2005) Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 25:820–828
Kontogianni K, Messini-Nikolaki N, Christou K, Gourgoulianis K, Tsilimigaki S, Piperakis SM (2007) DNA damage and repair capacity in lymphocytes from obstructive sleep apnea patients. Environ Mol Mutagen 48:722–727
Boulanger CM, Amabile N, Tedgui A (2006) Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 48:180–186
Yun CH, Jung KH, Chu K, Kim SH, Ji KH, Park HK, Kim HC, Lee ST, Lee SK, Roh JK (2010) Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea. J Clin Neurol 6:89–98
Ayers L, Ferry B, Craig S, Nicoll D, Stradling JR, Kohler M (2009) Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea. Eur Respir J 33:574–580
Akinnusi ME, El Solh AA (2009) Circulating endothelial microparticle levels and hemodynamic severity of pulmonary hypertension: is there a role for sleep apnea? Am J Respir Crit Care Med 179:328
Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor P, Le Jemtel TH (2009) Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea. Vasc Health Risk Manag 5:909–920
Kim J, Bhattacharjee R, Kheirandish-Gozal L et al (2011) Circulating microparticles in children with sleep disordered breathing. Chest (in press)
Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H (2005) Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 45:1622–1630
Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104:2649–2652
Mezentsev A, Merks RM, O'Riordan E, Chen J, Mendelev N, Goligorsky MS, Brodsky SV (2005) Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol 289:H1106–H1114
Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, Trinh A, Zupan M, Canuet M, Grunebaum L, Brunette A, Desprez D, Chabot F, Weitzenblum E, Freyssinet JM, Chaouat A, Toti F (2008) Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 177:536–543
Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS (2004) Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 286:H1910–H1915
Leroyer AS, Isobe H, Lesèche G, Castier Y, Wassef M, Mallat Z, Binder BR, Tedgui A, Boulanger CM (2007) Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 49:772–777
Priou P, Gagnadoux F, Tesse A, Mastronardi ML, Agouni A, Meslier N, Racineux JL, Martinez MC, Trzepizur W, Andriantsitohaina R (2010) Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea. Am J Pathol 177:974–983
Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600
Chu K, Jung KH, Lee ST, Park HK, Sinn DI, Kim JM, Kim DH, Kim JH, Kim SJ, Song EC, Kim M, Lee SK, Roh JK (2008) Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke. Stroke 39:1441–1447
Kheirandish-Gozal L, Bhattacharjee R, Kim J, Clair HB, Gozal D (2010) Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea. Am J Respir Crit Care Med 182:92–97
Zampetaki A, Kirton JP, Xu Q (2008) Vascular repair by endothelial progenitor cells. Cardiovasc Res 78:413–421
de la Peña M, Barceló A, Barbe F, Piérola J, Pons J, Rimbau E, Ayllón O, Agustí AG (2008) Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome. Respiration 76:28–32
Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, Klersy C, Pecci A, Moratti R, Tavazzi L (2005) Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105:199–206
Acknowledgement
This study was supported by grants from National Natural Science Foundation of China (Nos. 30800507 30770934).
Conflicts of interest
None of the authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Jing Feng and Dan Zhang contribute equally to this work.
Rights and permissions
About this article
Cite this article
Feng, J., Zhang, D. & Chen, B. Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea. Sleep Breath 16, 283–294 (2012). https://doi.org/10.1007/s11325-011-0519-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-011-0519-8